Wednesday, June 3, 2020

Gilead#39;s remdesivir could see $7 billion in annual sales on stockpiling boost: Analyst

Gilead#39;s remdesivir could see $7 billion in annual sales on stockpiling boost: Analyst The US drugmaker is yet to set a price for the drug that is currently being administered intravenously in hospitals.

from Moneycontrol Business News https://ift.tt/2U7W6rX

No comments:

Post a Comment

Nifty eyes relief rally on tariff hopes, FIIs remain a drag

Markets anticipate a rebound early in the shortened week following news of potential tariff removal on India. Despite oversold conditions, a...